Literature DB >> 29027228

High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair.

Marco E Bianchi1, Massimo P Crippa1, Angelo A Manfredi1, Rosanna Mezzapelle1, Patrizia Rovere Querini1, Emilie Venereau1.   

Abstract

A single protein, HMGB1, directs the triggering of inflammation, innate and adaptive immune responses, and tissue healing after damage. HMGB1 is the best characterized damage-associated molecular pattern (DAMP), proteins that are normally inside the cell but are released after cell death, and allow the immune system to distinguish between antigens that are dangerous or not. Notably, cells undergoing severe stress actively secrete HMGB1 via a dedicated secretion pathway: HMGB1 is relocated from the nucleus to the cytoplasm and then to secretory lysosomes or directly to the extracellular space. Extracellular HMGB1 (either released or secreted) triggers inflammation and adaptive immunological responses by switching among multiple oxidation states, which direct the mutually exclusive choices of different binding partners and receptors. Immune cells are first recruited to the damaged tissue and then activated; thereafter, HMGB1 supports tissue repair and healing, by coordinating the switch of macrophages to a tissue-healing phenotype, activation and proliferation of stem cells, and neoangiogenesis. Inevitably, HMGB1 also orchestrates the support of stressed but illegitimate tissues: tumors. Concomitantly, HMGB1 enhances the immunogenicity of mutated proteins in the tumor (neoantigens), promoting anti-tumor responses and immunological memory. Tweaking the activities of HMGB1 in inflammation, immune responses and tissue repair could bring large rewards in the therapy of multiple medical conditions, including cancer.
© 2017 The Authors. Immunological Reviews Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adaptive immunity; damage associate molecular pattern (DAMP); immunogenic cell death (ICD); inflammation; innate immunity; tissue repair

Mesh:

Substances:

Year:  2017        PMID: 29027228     DOI: 10.1111/imr.12601

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  98 in total

1.  Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models.

Authors:  Bin Du; David J Waxman
Journal:  Cancer Lett       Date:  2019-11-22       Impact factor: 8.679

2.  Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.

Authors:  Federica De Leo; Giacomo Quilici; Mario Tirone; Francesco De Marchis; Valeria Mannella; Chiara Zucchelli; Alessandro Preti; Alessandro Gori; Maura Casalgrandi; Rosanna Mezzapelle; Marco E Bianchi; Giovanna Musco
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

3.  All hands on DEK.

Authors:  David M Bodine
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

4.  Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury.

Authors:  Min-Jung Park; Louis G D'Alecy; Michelle A Anderson; Venkatesha Basrur; Yongjia Feng; Graham F Brady; Dong-Il Kim; Jun Wu; Alexey I Nesvizhskii; Joerg Lahann; Nicholas W Lukacs; Robert J Fontana; M Bishr Omary
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-12       Impact factor: 11.205

Review 5.  Dysregulated Th1 Immune and Vascular Responses in Scrub Typhus Pathogenesis.

Authors:  Lynn Soong
Journal:  J Immunol       Date:  2018-02-15       Impact factor: 5.422

6.  ResolvinD1 attenuates high-mobility group box 1-induced epithelial-to-mesenchymal transition in nasopharyngeal carcinoma cells.

Authors:  Pingli Yang; Shan Chen; Gang Zhong; Yan Wang; Weijia Kong; Yanjun Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-01

7.  Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure.

Authors:  Katelyn Arnold; Yongmei Xu; Erica M Sparkenbaugh; Miaomiao Li; Xiaorui Han; Xing Zhang; Ke Xia; Mark Piegore; Fuming Zhang; Xiaoxiao Zhang; Mike Henderson; Vijayakanth Pagadala; Guowei Su; Lisi Tan; Pyong Woo Park; Richard T Stravitz; Nigel S Key; Robert J Linhardt; Rafal Pawlinski; Ding Xu; Jian Liu
Journal:  Sci Transl Med       Date:  2020-03-18       Impact factor: 17.956

Review 8.  Regulation and Consequences of cGAS Activation by Self-DNA.

Authors:  Christian Zierhut; Hironori Funabiki
Journal:  Trends Cell Biol       Date:  2020-06-13       Impact factor: 20.808

Review 9.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

10.  Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasis.

Authors:  Miao Qiu; Keqing Huang; Yanzhuo Liu; Yuqing Yang; Honglin Tang; Xiaoxiao Liu; Chenlong Wang; Honglei Chen; Yu Xiong; Jing Zhang; Jing Yang
Journal:  Mucosal Immunol       Date:  2019-02-12       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.